OneThree Biotech

Drug Discovery Redesigned
With Biology Driven AI

OneThree has created one of the only AI-driven discovery  platforms with multiple clinical validations 

What we do

We create opportunities for new pipelines
through novel biological discoveries.


We have validated our ability to accurately predict novel targets, patient specific biomarkers, indications,
and identify optimal drug candidates to be repurposed towards those indications.

What we do

We create new therapeutic opportunities through novel biological discoveries.

We have validated our ability to identify novel targets, biomarkers, indications, and drug candidates for indications and patient populations.

Battle Tested

Our approach has been validated in cells, animals, and in the clinic.

With over 20 peer review journals, multiple case studies with industry leading partners, and success advancing lead candidates through clinical trials; we’re confident in our approach and have been recognized with countless speaking opportunities and awards.

We invite you to read more about our science in publications, cases studies, news and more. 

Battle Tested

Our approach has been validated in cells, animals, and in the clinic.

With over 20 peer review publications, multiple case studies with industry leading partners, and success advancing in house programs; we’re confident in our approach and have been recognized with countless speaking opportunities and awards.

We invite you to read more about our science, publications, cases studies, news, and more

Our Partners and Collaborators

Our technology has created higher clinical success rates for our partners and our internal pipeline.

Interested in Partnering?